Status:
COMPLETED
The Benefits of Deep Neuromuscular Block and Sugammadex in Laparoscopic Colorectal Surgery
Lead Sponsor:
Yonsei University
Conditions:
Colorectal Cancer
Eligibility:
All Genders
19-70 years
Phase:
NA
Brief Summary
Pneumoperitoneum, the use of carbon dioxide, presents some disadvantages, including a risk of hypercarbia and respiratory acidosis during surgery in the respiratory system, and of an increased mean ar...
Eligibility Criteria
Inclusion
- Patients aged 19 to 80 scheduled to undergo laparoscopic colorectal or rectal surgery below the ASA class 3
Exclusion
- Patients with neuromuscular disease/patients with a personal history or family history of malignant hyperthermia/patients with a serious heart, kidney (GFR \< 60) or liver condition (ALT/AST \> 100)/ patients who have had colorectal or rectal surgery/obese patients (BMI ≥35)
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT02266056
Start Date
August 1 2014
End Date
September 1 2015
Last Update
October 19 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei University, College of Medicine, Yonsei Health System, Yonsei Cancer Center
Seoul, Seoul, South Korea, 120-752